What is Regenxbio's other income (expense)?

Regenxbio (RGNX) reported other income (expense) of -$6.69M in Q1 2026.

How has Regenxbio's other income (expense) changed year-over-year?

Regenxbio's other income (expense) decreased by 10.7% year-over-year, from -$6.04M to -$6.69M.

What is the long-term trend for Regenxbio's other income (expense)?

Over 4 years (2021 to 2025), Regenxbio's other income (expense) has grown at a 14.9% compound annual growth rate (CAGR), from -$18.73M to -$32.68M.

What does other income (expense) mean?

Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.

Regenxbio RGNX Other Income (Expense)

Other Income (Expense) at other companies

Regeneron PharmaceuticalsREGN

$188.3M-39.9%

BiogenBIIB

-$1.1M-144%

EyePoint, Inc. EYPT

$2.34M-35.6%

4D Molecular TherapeuticsFDMT

$4.86M-14.0%

Solid Biosciences Inc.SLDB

$571K-25.8%

BioMarin PharmaceuticalsBMRN

——

Other financials

Income statement

See full

Revenue$6.4M-92.8%

Gross profit$14.9M+35.7%

Operating income-$83.4M-787%

Net income-$90.1M-1,580%

EPS (diluted)-$1.72-1,533%

Balance sheet

See full

Cash & equivalents$15.2M-88.3%

Total debt$71.1M-11.0%

Total equity$21.1M-92.3%

Total assets$341.9M-30.4%

Cash flow

See full

Operating cash flow-$76.2M-327%

CapEx$1.2M+20.6%

Free cash flow-$77.4M-337%

Valuation

See full

Market cap$529.38M+24.6%

Enterprise value$585.22M+56.3%

P/S6×+3.3×

Profitability

See full

Gross margin59.7%+1.0pp

Operating margin-292.3%-613pp

Net margin-330.2%-588pp

FCF margin-269.2%-364pp

Returns & leverage

See full

Return on equity-196.4%-288pp

Debt / equity3.4×+3.1×

Current ratio2.6×-0.3×

Where this comes from

Reported directly by Regenxbio in its filing.

Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.

The official record: Regenxbio’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Regenxbio's other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Regenxbio's other income (expense)?: Regenxbio (RGNX) reported other income (expense) of -$6.69M in Q1 2026.
How has Regenxbio's other income (expense) changed year-over-year?: Regenxbio's other income (expense) decreased by 10.7% year-over-year, from -$6.04M to -$6.69M.
What is the long-term trend for Regenxbio's other income (expense)?: Over 4 years (2021 to 2025), Regenxbio's other income (expense) has grown at a 14.9% compound annual growth rate (CAGR), from -$18.73M to -$32.68M.
What does other income (expense) mean?: Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.